Status:
WITHDRAWN
Steroids Helping Albuterol Responders Exclusively
Lead Sponsor:
University Hospitals Cleveland Medical Center
Conditions:
Bronchiolitis
Eligibility:
All Genders
4-24 years
Phase:
NA
Brief Summary
The purpose of the study is to determine whether corticosteroids are beneficial to children with bronchiolitis whose breathing gets better after being given a breathing treatment with albuterol.
Eligibility Criteria
Inclusion
- diagnosis of bronchiolitis
- Respiratory Distress Assessment Index score of 4 or more
Exclusion
- prior prescription of bronchodilators or inhaled corticosteroids
- birth at \<36 weeks gestation
- chronic cardiac disease
- chronic pulmonary disease (including asthma)
- immunodeficiency
- non-topical steroid use in the prior week
- parents that don't understand English
- baseline systolic blood pressure \>118 mmHg
- home oxygen use
- evidence of systemic fungal or varicella infection
- bronchodilator use in the prior week
- allergy to albuterol or corticosteroids
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00798616
Last Update
December 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of Cleveland
Cleveland, Ohio, United States, 44106